Back to Search
EDNA FRANCESCHI, MD
MD
General Practice Physician
NPI: 1508069030Individual
Specialties, Licenses & Credentials
General Practice PhysicianPrimary
General Practice
Code: 208D00000X
9864(PR)
Research & Publications (20)
Treatment options for recurrent glioblastoma: pitfalls and future trends.
PMID 19445578·Expert Rev Anticancer Ther·2009
6-review
Adult neuroectodermal tumors of posterior fossa (medulloblastoma) and of supratentorial sites (stPNET).
PMID 19303318·Crit Rev Oncol Hematol·2009
6-review
Recurrence pattern after temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation With MGMT promoter methylation status.
PMID 19188675·J Clin Oncol·2009
8-other
Fotemustine as second-line treatment for recurrent or progressive glioblastoma after concomitant and/or adjuvant temozolomide: a phase II trial of Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
PMID 19169684·Cancer Chemother Pharmacol·2009
3-trial
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status.
PMID 19514084·Cancer·2009
8-other
Association between response to primary treatments and MGMT status in glioblastoma.
PMID 18983238·Expert Rev Anticancer Ther·2008
6-review
Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
PMID 18953566·Virchows Arch·2008
8-other
Chemotherapy in breast cancer patients with brain metastases: have new chemotherapic agents changed the clinical outcome?
PMID 18550383·Crit Rev Oncol Hematol·2008
6-review
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
PMID 18445844·J Clin Oncol·2008
8-other
Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas.
PMID 18431544·J Neurooncol·2008
3-trial
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology.
PMID 18401015·Neuro Oncol·2008
6-review
Epidermal growth factor receptor inhibitors in neuro-oncology: hopes and disappointments.
PMID 18281526·Clin Cancer Res·2008
6-review
Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO).
PMID 17353924·Br J Cancer·2007
3-trial
Long-term results of a prospective study on the treatment of medulloblastoma in adults.
PMID 17823910·Cancer·2007
3-trial
Adjuvant therapy in glioblastomas: false steps and real advances.
PMID 17492923·Expert Rev Anticancer Ther·2007
8-other
Challenges and progress in the treatment of adult medulloblastomas.
PMID 17381408·Future Oncol·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 39 PARQUE INTERAMERICANA CALLEZ
GUAYAMA, PR 00784 - Phone
- (787) 866-5192
Quick Facts
- NPI
- 1508069030
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile